Biotech Startups
10,066 companies tagged Biotech, with their investors and founders.
Probiotic Holdings is an institutional developer of probiotic and biochemical technology applications, identifying and developing technologies for commercialization. The company operates through its subsidiary SCD Probiotics, which develops and markets probiotic products for health and environmental applications.
0 investors
0 investors
0 investors
0 investors
0 investors
Prolifagen develops microRNA (miR) technology to stimulate the regeneration of heart muscle damaged by myocardial infarction, aiming to prevent scar tissue formation and restore cardiac function. The company targets physicians and heart attack patients seeking solutions to prevent heart failure and recurrent cardiac events.
0 investors
0 investors
0 investors
0 investors
0 investors
PROMISS Diagnostics develops diagnostic tools that apply analytics to common blood tests to expand their diagnostic capability. The company focuses on affordable, accessible medical diagnostics in the healthcare and life sciences space.
0 investors
0 investors
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for substance use disorders and specialty central nervous system (CNS) conditions, including treatments for opioid withdrawal and seizure disorders.
0 investors
0 investors
0 investors
Propedix is a biopharma and consumer health company developing topical treatments for dermatological conditions and skin infections, such as athlete's foot and other fungal conditions. Its first product, Dryello, is a dermatologist-developed topical treatment for athlete's foot backed by clinical research.
0 investors
ProPhase Labs appears to operate multiple subsidiary companies including Nebula Genomics, ProPhase Biopharma, and TK Supplements, but detailed information about the company's primary business, products, and market focus is not available on this investor relations presentations page.
0 investors
Propria develops a patented system for producing and analyzing human engineered heart tissue (hEHT), generating detailed datasets on the contractile function of human cardiac tissue. It serves academic groups, pharmaceutical companies, and biotech and gene therapy firms.
0 investors
0 investors
0 investors
0 investors
Protagenic Therapeutics develops therapeutic treatments focused on the body's stress response and healing processes for patients with psychological, physical, and medical conditions.
0 investors
0 investors
Protaryx is a medical device company developing cardiac technology, led by a team including a cardiac surgeon and executives with device-industry backgrounds.
0 investors